A

Adaptimmune Therapeutics plc
D

ADAP

0.064200
USD
-0.01
(-8.29%)
مغلق
حجم التداول
377,782
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
17,016,312
الأخبار المقالات

العنوان: Adaptimmune Therapeutics plc

القطاع: Healthcare
الصناعة: Biotechnology
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.